Everence Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Sell |
3,030
-471
| -13% | -$247K | 0.1% | 169 |
|
|
2025
Q1 | $2.22M | Sell |
3,501
-330
| -9% | -$209K | 0.15% | 123 |
|
|
2024
Q4 | $2.73M | Buy |
3,831
+90
| +2% | +$64.1K | 0.18% | 96 |
|
|
2024
Q3 | $3.93M | Hold |
3,741
| – | – | 0.25% | 71 |
|
|
2024
Q2 | $3.33K | Hold |
3,741
| – | – | 0.23% | 80 |
|
|
2024
Q1 | $3.6K | Hold |
3,741
| – | – | 0.24% | 83 |
|
|
2023
Q4 | $3.29M | Buy |
3,741
+70
| +2% | +$61.5K | 0.23% | 85 |
|
|
2023
Q3 | $3.02K | Hold |
3,671
| – | – | 0.23% | 84 |
|
|
2023
Q2 | $2.7M | Hold |
3,671
| – | – | 0.22% | 88 |
|
|
2023
Q1 | $3.02K | Hold |
3,671
| – | – | 0.25% | 78 |
|
|
2022
Q4 | $2.65K | Hold |
3,671
| – | – | 0.23% | 91 |
|
|
2022
Q3 | $2.53M | Buy |
3,671
+570
| +18% | +$393K | 0.23% | 78 |
|
|
2022
Q2 | $1.83M | Hold |
3,101
| – | – | 0.16% | 116 |
|
|
2022
Q1 | $2.17M | Hold |
3,101
| – | – | 0.17% | 118 |
|
|
2021
Q4 | $1.96M | Buy |
3,101
+600
| +24% | +$379K | 0.15% | 125 |
|
|
2021
Q3 | $1.51M | Hold |
2,501
| – | – | 0.12% | 142 |
|
|
2021
Q2 | $1.4M | Hold |
2,501
| – | – | 0.11% | 151 |
|
|
2021
Q1 | $1.18M | Hold |
2,501
| – | – | 0.11% | 161 |
|
|
2020
Q4 | $1.21M | Buy |
2,501
+260
| +12% | +$126K | 0.12% | 142 |
|
|
2020
Q3 | $1.25M | Buy |
2,241
+20
| +0.9% | +$11.2K | 0.14% | 129 |
|
|
2020
Q2 | $1.36M | Hold |
2,221
| – | – | 0.16% | 111 |
|
|
2020
Q1 | $1.08M | Hold |
2,221
| – | – | 0.15% | 119 |
|
|
2019
Q4 | $834K | Buy |
2,221
+660
| +42% | +$248K | 0.12% | 172 |
|
|
2019
Q3 | $433K | Hold |
1,561
| – | – | 0.07% | 308 |
|
|
2019
Q2 | $489K | Hold |
1,561
| – | – | 0.08% | 265 |
|
|
2019
Q1 | $641K | Sell |
1,561
-176
| -10% | -$72.3K | 0.11% | 193 |
|
|
2018
Q4 | $649K | Hold |
1,737
| – | – | 0.15% | 164 |
|
|
2018
Q3 | $702K | Hold |
1,737
| – | – | 0.14% | 180 |
|
|
2018
Q2 | $599K | Hold |
1,737
| – | – | 0.13% | 197 |
|
|
2018
Q1 | $598K | Hold |
1,737
| – | – | 0.13% | 193 |
|
|
2017
Q4 | $653K | Hold |
1,737
| – | – | 0.14% | 176 |
|
|
2017
Q3 | $777K | Buy |
1,737
+510
| +42% | +$228K | 0.18% | 157 |
|
|
2017
Q2 | $603K | Hold |
1,227
| – | – | 0.15% | 185 |
|
|
2017
Q1 | $475K | Hold |
1,227
| – | – | 0.12% | 210 |
|
|
2016
Q4 | $450K | Sell |
1,227
-535
| -30% | -$196K | 0.13% | 202 |
|
|
2016
Q3 | $708K | Hold |
1,762
| – | – | 0.21% | 139 |
|
|
2016
Q2 | $615K | Hold |
1,762
| – | – | 0.19% | 152 |
|
|
2016
Q1 | $635K | Hold |
1,762
| – | – | 0.2% | 149 |
|
|
2015
Q4 | $957K | Buy |
1,762
+322
| +22% | +$175K | 0.31% | 93 |
|
|
2015
Q3 | $670K | Hold |
1,440
| – | – | 0.23% | 132 |
|
|
2015
Q2 | $735K | Hold |
1,440
| – | – | 0.24% | 132 |
|
|
2015
Q1 | $596K | Hold |
1,440
| – | – | 0.2% | 153 |
|
|
2014
Q4 | $591K | Buy |
+1,440
| New | +$591K | 0.2% | 151 |
|